Markets.com Logo

KZIA

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    7.2168$
  • Previous Close
    7.2495$
  • 52 Week Change
    36.19$
  • Day Range
    -0.03$
  • 52 Week High/Low
    2.86$ - 39.05$
  • Dividend Per Share
    --
  • Market cap
    9 925 K$
  • EPS
    -12.3
  • Beta
    2.649
  • Volume
    --

About

Kazia Therapeutics Limited (KZIA.US) is an Australian oncology-focused drug development company, primarily focusing on developing innovative therapies for cancer. Their lead candidate is paxalisib, a brain-penetrant PI3K / Akt / mTOR pathway inhibitor, being developed for glioblastoma and other cancers. They are also developing EVT801, a selective inhibitor of VEGFR3, which is currently in a Phase I clinical trial. The company is listed on the NASDAQ under the symbol KZIA.
Commodity Market Analysis: UAE Fuel Prices Surge Up to 72% in April 2026 as Global Oil Rally

Commodity Market Analysis: UAE Fuel Prices Surge Up to 72% in April 2026 as Global Oil Rally

Ghko B|--
DAX 40 Index Analysis Today: Why the German Benchmark Is Struggling Near 23,500

DAX 40 Index Analysis Today: Why the German Benchmark Is Struggling Near 23,500

Ghko B|--
Gold price analysis (XAU/USD): Will gold rate decrease in coming days in 2026?

Gold price analysis (XAU/USD): Will gold rate decrease in coming days in 2026?

Ghko B|--
Solana price analysis: Solana (SOL/USD) price slid lower, what’s happening with SOL?

Solana price analysis: Solana (SOL/USD) price slid lower, what’s happening with SOL?

Frances Wang|--
Bitcoin Analysis Today: Bitcoin Holds Strong Above $70K as Bulls Defend Key Support Level

Bitcoin Analysis Today: Bitcoin Holds Strong Above $70K as Bulls Defend Key Support Level

Ghko B|--
Microsoft's SWOT analysis: Why MSFT Is the best AI stock to buy in 2026?

Microsoft's SWOT analysis: Why MSFT Is the best AI stock to buy in 2026?

Ghko B|--
FTSE 100 analysis: FTSE 100 falls below 10,350, what’s next for UK stock market?

FTSE 100 analysis: FTSE 100 falls below 10,350, what’s next for UK stock market?

Frances Wang|--

Factors

[Clinical Trial Results]: Positive outcomes in trials for their cancer therapies typically boost the stock. Negative results can lead to a significant price drop.

[Regulatory Decisions]: FDA approvals or rejections of their drugs are major price drivers. Approval leads to revenue potential, rejection severely limits growth prospects.

[Market Sentiment]: Overall market conditions, particularly in the biotech sector, affect KZIA.US. A bullish market can lift all stocks, a bearish market can drag them down.

[Partnerships and Collaborations]: Deals with larger pharmaceutical companies can validate their technology and provide funding, positively influencing the stock price.

[Financial Performance]: Cash burn rate, available funding, and future funding needs impact investor confidence and thus, the stock price. Concerns about funding can lower the price.

People Also Watch

Latest news

Gold Price Today, April 14: Gold Dips Below $4,800 While Silver Holds Above $75 Amid Renewed Inflation Fears

Gold Price Today, April 14: Gold Dips Below $4,800 While Silver Holds Above $75 Amid Renewed Inflation Fears

Ghko B|--
Commodity Market Today: Gold and Silver Prices Swing Wildly as Fragile US-Iran Ceasefire Shows Cracks

Commodity Market Today: Gold and Silver Prices Swing Wildly as Fragile US-Iran Ceasefire Shows Cracks

Ghko B|--
UAE Economy News: Non-Oil Sectors Drive Growth as Abu Dhabi Prepares for 2029 IMF Meetings

UAE Economy News: Non-Oil Sectors Drive Growth as Abu Dhabi Prepares for 2029 IMF Meetings

Ghko B|--

Latest Education Articles

CFDs vs Stocks: What’s the Difference & Which Should You Trade in 2026?

CFDs vs Stocks: What’s the Difference & Which Should You Trade in 2026?

Julian Parker|--
Global Index CFDs Guide 2026 | How to Trade Index CFDs

Global Index CFDs Guide 2026 | How to Trade Index CFDs

Julian Parker|--
Bitcoin CFDs: What Are They and How Do They Work?

Bitcoin CFDs: What Are They and How Do They Work?

Julian Parker|--